Primary Site >> Esophagus Cancer

Gene >> SLC52A3

Journal: Mol Biol Rep. 2012 Sep;39(9):9105-11.
Title: Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population.
Author: Gu, Haiyong|Ding, Guowen|Zhang, Wenbo|Liu, Chao|Chen, Yijang|Chen, Suocheng|Jiang, Pengcheng
PMID: 22744421
Journal: Eur J Cancer Prev. 2013 Sep;22(5):417-9.
Title: GWAS-uncovered SNPs in PLCE1 and RFT2 genes are not implicated in Dutch esophageal adenocarcinoma and squamous cell carcinoma etiology.
Author: Dura, Polat|Bregitha, Caro V V|te Morsche, Rene H M|Roelofs, Hennie M J|Kristinsson, Jon O|Wobbes, Theo|Witteman, Ben J M|Tan, Adriaan C I T L|Drenth, Joost P H|Peters, Wilbert H M
PMID: 23222411
Journal: Mol Biol Rep. 2013 May;40(5):3769-75.
Title: Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.
Author: Ainiwaer, Julaiti|Tuerhong, Abuduaini|Hasim, Ayshamgul|Chengsong, Du|Liwei, Zhang|Sheyhidin, Ilyar
PMID: 23275236
Journal: Biomark Med. 2016 Oct;10(10):1105-1118. Epub 2016 Sep 7.
Title: Decreased risk of developing cancer in subjects carrying SLC52A3 rs13042395 polymorphism: proof from a meta-analysis.
Author: Li, Jun|Wang, Shilong|Li, Man|Xu, Hui|Li, Dandan|Yin, Can|Zhao, Jin|Li, Feng
PMID: 27600099
Journal: Cell Mol Life Sci. 2018 Jul;75(14):2643-2661.
Title: SLC52A3 expression is activated by NF-kappaB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.
Author: Long, Lin|Pang, Xiao-Xiao|Lei, Fei|Zhang, Jia-Sheng|Wang, Wei|Liao, Lian-Di|Xu, Xiu-E|He, Jian-Zhong|Wu, Jian-Yi|Wu, Zhi-Yong|Wang, Li-Dong|Lin, De-Chen|Li, En-Min|Xu, Li-Yan
PMID: 29428966